Newsfeeds - Spark Newswire

4 minute read

63 Biggest Movers From Yesterday

Today, 1:14 PM

Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.

ACIU

3 minute read

Mid-Afternoon Market Update: Dow Dips 900 Points; AC Immune Shares Slide

By Lisa Levin

Today, 1:14 PM

U.S. stocks traded lower toward the end of trading, after the Federal Reserve raised fed funds rates by 0.75% to a new target range of between 1.5% and 1.75% on Wednesday.

ACIU

3 minute read

Mid-Day Market Update: Dow Tumbles 700 points; Advent Technologies Shares Spike Higher

By Lisa Levin

Today, 1:14 PM

U.S. stocks traded lower midway through trading, after the Federal Reserve raised fed funds rates by 0.75% to a new target range of between 1.5% and 1.75% on Wednesday.

ACIU

3 minute read

37 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 1:14 PM

Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares jumped 153% to $2.94 after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.

ACIU

4 minute read

The Daily Biotech Pulse: Roche’s Alzheimer’s Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK

By Vandana Singh

Today, 1:14 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ACIU

3 minute read

Mid-Morning Market Update: Markets Open Lower; US Jobless Claims Fall To 229,000

By Lisa Levin

Today, 1:14 PM

U.S. stocks traded lower this morning, after the Federal Reserve raised interest rates by 0.75% on Wednesday.

ACIU

1 minute read

Roche-AC Immune’s Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer’s Patients

By Vandana Singh

Today, 1:14 PM

Roche Holdings AG (OTC:RHHBY) said its Alzheimer’s medicine crenezumab did not slow or prevent cognitive decline in people with a specific…

ACIU

1 minute read

Legal
News

AC Immune Granted European Patent Titled ‘1,3,4,5-TETRAHYDRO-2H-PYRIDO[4,3-B] INDOLE DERIVATIVES FOR THE TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES LIKE ALZHEIMER’S DISEASE’

By Benzinga Newsdesk

Today, 1:14 PM

https://register.epo.org/application?number=EP19700206

ACIU

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 1:14 PM

On Wednesday, 807 companies reached new 52-week lows.

AADI

3 minute read

AC Immune Reports Its Anti-Abeta Vaccine Results From Phase 1b Study In Down Syndrome Were Published In ‘JAMA Neurology’

By Benzinga Newsdesk

Today, 1:14 PM

First study of an anti-Abeta vaccine in people living with Down syndrome (DS) Immune response and Alzheimer’s disease (AD) biomarkers showed positive impact of ACI-24 first generation vaccine Optimized

ACIU